Neuraxpharm And Panaxia Pioneer Medical Cannabis Extract For Vaporization In Europe
Partnering Companies Start With Germany Under Joint Brand Naxiva-Panaxol
Neuraxpharm and Panaxia have become the first companies in the world to market medical cannabis extract, under the joint brand Naxiva-Panaxol, for vaporization in Germany. Under the agreement, the extracts will be manufactured by Panaxia and marketed in Germany by Neuraxpharm.
You may also be interested in...
Medical Cannabis Taboo Challenged By Neuraxpharm Campaign
Neuraxpharm has launched its Change for Health campaign, which aims to increase awareness and bust misconceptions about the use of medical cannabis.
Panaxia And Neuraxpharm Sign To Sell Medical Cannabis In The Czech Republic And Switzerland
Panaxia and Neuraxpharm have added the Czech Republic and Switzerland to their growing list of European markets for medical cannabis. Both countries have passed recent legislation to stimulate prescriptions of cannabis products.
Neuraxpharm Boosts Branded Business With Established Sanofi Portfolios
CNS specialist Neuraxpharm has purchased two of Sanofi’s product portfolios, substantially expanding the number of branded products it has to offer.